Positive Pressure During Bronchoscopy
1 other identifier
interventional
24
1 country
1
Brief Summary
It has been demonstrated the application of noninvasive positive pressure ventilation (NPPV) to assist spontaneous breathing through a face mask during fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) in severely hypoxemic, nonintubated patients. With NPPV, FOB was well-tolerated, significantly improved the PaO2/FiO2 ratio, and successfully avoided the need for endotracheal intubation. Two randomized studies have provided supporting evidence that the application of NPPV or CPAP via a face mask was superior to oxygen supplementation alone during FOB. For this reason patients who require FOB and are hypoxemic and/or mild hypercapnic (TcCO2 \< 60mmHg) will be compared in a randomized study by comparing NPPV vs CPAP Boussignac (Vygon) delivered through a face mask.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 15, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedFirst Posted
Study publicly available on registry
June 19, 2014
CompletedJune 19, 2014
June 1, 2014
7 months
September 15, 2011
June 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in arterial parcial oxygen pressure / Inspired oxygen fraction ratio (PaO2/FiO2)
Before and 5 min after the exam (FOB)
Secondary Outcomes (4)
Electrocardiogram
up to 60 min after FOB
Heart Rate
up to 60 min after FOB
Respiratory Rate
up to 60 min after FOB
Peripheal oxygen saturation
up to 60 min after FOB
Study Arms (2)
NPPV group
EXPERIMENTALPatients assigned to noninvasive positive pressure ventilation (NPPV) are connected to the ventilator through a face mask (VBM Endoscopy Mask) that is secured to the patient's face by the investigator.
CPAP valve group
ACTIVE COMPARATORPatients assigned to CPAP valve (Boussignac valve, Vygon, Inc) are connected to this device through a standard face mask that is secured to the patient's face with elastic straps.
Interventions
Patients assigned to NPPV were connected to the ventilator through a face mask (VBM Endoscopy Mask) that was secured to the patient's face by the investigator. Only one type of mechanical ventilator will be used (Vision, Philips Respironics). Ventilator parameters and supplemental oxygen will be titrated by the investigator to achieve SpO2\>92%. Ventilatory support via face mask will be maintained with the same pressures for at least 30min after FOB, and then will be replaced by the FIO2 mask's if needed.
Patients assigned to CPAP Boussignac valve are connected to this device through a face mask that is secured to the patient's face with elastic straps. This kind of CPAP allows the delivery of pressure by constant-flow oxygen insufflation. Four funnel-shaped microchannels are included in the wall of this device and connected to an external opening connected to the oxygen source. These microchannels generate high-velocity microjets, which in turn generate the pressure resulting from the air entrainment mechanism thus created. Oxygen flow will be titrated by the investigator to ensure SpO2\>92%.
Eligibility Criteria
You may qualify if:
- need for FOB;
- hypoxemia, defined by pulse oximetry (SpO2) \>92% under oxygen supplementation;
- mild hypercapnia, defined by transcutaneous CO2 (PaCO2) \<60mmHg;
- already under domiciliary NPPV.
You may not qualify if:
- emergent intubation;
- recent (less than 1 wk) acute myocardial infarction;
- ph bellow 7.30;
- PaCo2 \> 60mmHg;
- systolic blood pressure \< 80mmHg;
- encephalopathy or coma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Broncology Unit, Pulmonology Department, University Hospital São João
Porto, Porto District, 4200-319, Portugal
Related Publications (1)
Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, Meduri GU. Noninvasive positive-pressure ventilation vs. conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest. 2002 Apr;121(4):1149-54. doi: 10.1378/chest.121.4.1149.
PMID: 11948045BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miguel R Gonçalves, Ph.D
Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João
- PRINCIPAL INVESTIGATOR
Tiago F Pinto, MSc
Lung Function and Ventilation Unit, Pulmonology Department, University Hospital São João
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
September 15, 2011
First Posted
June 19, 2014
Study Start
February 1, 2010
Primary Completion
September 1, 2010
Study Completion
February 1, 2014
Last Updated
June 19, 2014
Record last verified: 2014-06